Exeliom Biosciences Email Format
Pharmaceutical ManufacturingBourgogne-franche-comté, France2-10 Employees
Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies for immuno-oncology and immuno-inflammation. Its candidates are designed to harness microbiome-associated mechanisms that regulate innate immune responses. Based in Dijon, Bourgogne-Franche-Comté, France, the firm operates with a small team. The information provided does not specify a defined customer base or target market. Within the pharmaceutical manufacturing landscape, Exeliom is positioned as a clinical-stage entity advancing its immunotherapy programs. In 2025, the company announced the launch of LIVEDIFF Part 2.